enVVeno Medical CorporationNVNONASDAQ
LOADING
|||
Switch Symbol:
Operating Income Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year operating income growth rate
Latest
30.73%
↑ 336% above average
Average (39q)
-13.00%
Historical baseline
Range
High:52.19%
Low:-232.24%
Volatility
-2187.9%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | 30.73% |
| Q2 2025 | -42.29% |
| Q1 2025 | 26.05% |
| Q4 2024 | -8.57% |
| Q3 2024 | -13.13% |
| Q2 2024 | 0.89% |
| Q1 2024 | 12.34% |
| Q4 2023 | -17.37% |
| Q3 2023 | 21.50% |
| Q2 2023 | -0.25% |
| Q1 2023 | -5.22% |
| Q4 2022 | -5.02% |
| Q3 2022 | 11.95% |
| Q2 2022 | -30.95% |
| Q1 2022 | 40.67% |
| Q4 2021 | -232.24% |
| Q3 2021 | -13.46% |
| Q2 2021 | 15.06% |
| Q1 2021 | 32.47% |
| Q4 2020 | -116.33% |
| Q3 2020 | -24.35% |
| Q2 2020 | -2.48% |
| Q1 2020 | 11.79% |
| Q4 2019 | 6.75% |
| Q3 2019 | 6.42% |
| Q2 2019 | -23.86% |
| Q1 2019 | 12.04% |
| Q4 2018 | -20.92% |
| Q3 2018 | 52.19% |
| Q2 2018 | -113.66% |
| Q1 2018 | 24.49% |
| Q4 2017 | -6.43% |
| Q3 2017 | -47.12% |
| Q2 2017 | -8.94% |
| Q1 2017 | 30.36% |
| Q4 2016 | -53.12% |
| Q3 2016 | -42.56% |
| Q2 2016 | 0.00% |
| Q1 2016 | -27.46% |
| Q4 2015 | 0.00% |